Exome Asset Management LLC

Exome Asset Management LLC reported 55 holdings worth US$153M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Exome Asset Management LLC reported 55 holdings worth US$153M as of Sep 30, 2026. Largest: Guardant Health, Inc., TG Therapeutics, Inc. and Abivax SA. Filed Nov 16, 2026 (Form 13F).

Holdings
55
Value as reported
US$153M

The filing in full

CompanySharesValue as reported% of portfolio
Guardant Health, Inc.67,500US$12M7.9%
TG Therapeutics, Inc.188KUS$10.5M6.8%
Abivax SA90,919US$9M5.9%
Praxis Precision Medicines, Inc.29,681US$8.64M5.6%
Cogent Biosciences, Inc.211KUS$6.74M4.4%
Eli Lilly and Company5,492US$6.35M4.2%
Natera, Inc.13,800US$5.7M3.7%
Vera Therapeutics, Inc.160KUS$5.15M3.4%
Viking Therapeutics, Inc.147KUS$4.81M3.1%
Ionis Pharmaceuticals, Inc.107KUS$4.78M3.1%
Enliven Therapeutics, Inc.100KUS$4.59M3.0%
Caris Life Sciences, Inc.146KUS$4.47M2.9%
Nektar Therapeutics73,708US$4.46M2.9%
Cytokinetics, Incorporated60,056US$3.96M2.6%
Verastem, Inc.429KUS$3.45M2.3%
Maze Therapeutics, Inc.115KUS$3.12M2.0%
Rhythm Pharmaceuticals, Inc.32,209US$3.07M2.0%
10x Genomics, Inc.30,074US$2.72M1.8%
United Therapeutics Corporation4,109US$2.23M1.5%
Boston Scientific Corporation48,347US$2.11M1.4%
Arrowhead Pharmaceuticals, Inc.32,214US$2.11M1.4%
UnitedHealth Group Incorporated5,697US$2.09M1.4%
Ocular Therapeutix, Inc.272KUS$2.09M1.4%
Alumis Inc.282KUS$2.09M1.4%
Penumbra, Inc.6,300US$2.01M1.3%
Intuitive Surgical, Inc.4,908US$2M1.3%
COMPASS Pathways Plc153KUS$1.9M1.2%
Celldex Therapeutics, Inc.56,269US$1.82M1.2%
Merck & Company, Inc.12,358US$1.8M1.2%
Liquidia Corporation59,155US$1.79M1.2%
Glaukos Corporation10,862US$1.78M1.2%
Monte Rosa Therapeutics, Inc.137KUS$1.63M1.1%
BridgeBio Pharma, Inc.21,209US$1.4M0.91%
ClearPoint Neuro Inc.110KUS$1.35M0.88%
Corbus Pharmaceuticals Holdings, Inc.191KUS$1.3M0.85%
CytomX Therapeutics, Inc.460KUS$1.25M0.82%
Palvella Therapeutics, Inc.7,809US$1.08M0.70%
Rapport Therapeutics, Inc.29,381US$987K0.65%
BillionToOne, Inc.8,983US$956K0.62%
Zenas BioPharma, Inc.34,341US$926K0.61%
Replimune Group, Inc.68,488US$907K0.59%
Equillium, Inc.553KUS$899K0.59%
Establishment Labs Holdings Inc.13,100US$841K0.55%
Climb Bio, Inc.71,215US$817K0.53%
NovaBridge Biosciences577KUS$788K0.51%
Bright Minds Biosciences Inc.14,715US$733K0.48%
Compass Therapeutics, Inc.511KUS$532K0.35%
Q32 Bio Inc.62,589US$518K0.34%
Capricor Therapeutics, Inc.51,531US$488K0.32%
Arbutus Biopharma Corporation50,166US$240K0.16%
Adagene, Inc.52,543US$168K0.11%
Geron Corporation0US$00.00%
Insmed Incorporated0US$00.00%
Relay Therapeutics, Inc.0US$00.00%
Crescent Biopharma, Inc.0US$00.00%
Agios Pharmaceuticals, Inc.0US$00.00%

Source

Download original · View original at SEC

Related